Recurrent Implantation Failure: Why Good Embryos Sometimes Don’t Implant

Recurrent implantation failure can be one of the most frustrating experiences during IVF treatment.

Everything may appear to be going well. Good-quality embryos have developed. The endometrium appears suitable. Embryo transfer is uncomplicated. Yet pregnancy does not occur.

After repeated unsuccessful embryo transfers, many patients understandably ask:

“If the embryos are good, why don’t they implant?”

The answer is rarely explained by one factor alone.

Embryo implantation is an exceptionally complex biological process requiring successful interaction between the embryo, the endometrium and the wider uterine environment.

When implantation repeatedly fails, evaluation may therefore involve several areas: embryo competence, maternal age, uterine anatomy, endometrial development, inflammation, endometriosis or adenomyosis, male fertility factors and previous embryo-transfer characteristics.

At the same time, modern reproductive medicine increasingly recognizes that recurrent implantation failure should be evaluated individually. The number and quality of embryos transferred, whether embryos were genetically tested, female age and the expected probability of implantation all influence how repeated unsuccessful transfers should be interpreted.

Understanding these factors can help identify a more targeted strategy before the next embryo transfer.

What Is Recurrent Implantation Failure?

Recurrent implantation failure, commonly abbreviated as RIF, refers broadly to repeated failure to establish pregnancy following embryo transfer.

However, there is no single number of failed transfers that has exactly the same clinical meaning for every patient.

Modern IVF has changed substantially through:

• Blastocyst-stage embryo transfer
• Single-embryo transfer
• Improved embryo culture
• Frozen embryo transfer
• Preimplantation genetic testing
• Improved embryo selection

As a result, the meaning of two or three unsuccessful transfers can differ considerably from one woman to another.

For example, repeated transfer of untested embryos in a woman over 40 presents a different biological situation from repeated transfer of euploid blastocysts in a younger woman.

The assessment of recurrent implantation failure should therefore consider the patient’s individual probability of implantation rather than relying exclusively on an arbitrary number of failed transfers.

How Does Embryo Implantation Work?

Implantation begins when a developing blastocyst reaches and interacts with the endometrium, the specialized inner lining of the uterus.

Successful implantation requires several coordinated events.

The embryo must reach an appropriate stage of development.

The endometrium must become receptive.

The embryo and endometrium must exchange molecular signals.

The blastocyst must attach to the endometrial surface and subsequently invade the tissue.

Blood vessels and early placental structures must then develop to support the pregnancy.

Implantation is therefore much more than an embryo simply “sticking” to the uterus.

It represents a highly coordinated biological conversation between embryo and mother.

Disruption at different stages of this process may contribute to implantation failure.

Why Can a Good-Quality Embryo Fail to Implant?

This is one of the most common questions after an unsuccessful embryo transfer.

Patients may have been told that they had an excellent-quality blastocyst and understandably expect pregnancy to follow.

However, embryo quality as assessed in the laboratory is largely based on morphology and developmental characteristics.

Embryologists may assess:

• Blastocyst expansion
• Inner cell mass appearance
• Trophectoderm appearance
• Developmental timing
• Cell organization
• Fragmentation at earlier stages

These characteristics are extremely useful, but they cannot reveal every aspect of an embryo’s biological potential.

A morphologically excellent embryo may still have chromosomal, metabolic or developmental factors that reduce its ability to implant.

Likewise, embryos with less-than-perfect morphology can sometimes produce healthy pregnancies.

Therefore, a “good-quality embryo” means that several favorable characteristics are present—not that implantation is guaranteed.

1. Embryo Chromosomal Abnormalities

One of the most important factors affecting implantation is the chromosome complement of the embryo.

An embryo with an abnormal number of chromosomes is described as aneuploid.

Aneuploid embryos may:

• Stop developing
• Fail to implant
• Implant temporarily
• Result in biochemical pregnancy
• Contribute to miscarriage

The likelihood of embryo aneuploidy increases significantly with maternal age.

This means that embryo-related factors remain an important consideration when evaluating repeated implantation failure, particularly when untested embryos have been transferred.

2. Female Age

Female age is closely connected to embryo competence because the probability of chromosomal abnormalities in oocytes increases as reproductive age advances.

This is especially relevant after the late 30s and into the 40s.

Consequently, repeated unsuccessful embryo transfers should always be interpreted in relation to age.

For a woman over 40 using her own eggs, embryo competence may contribute substantially to unsuccessful transfers.

In a younger woman with repeated transfer of high-quality embryos, the relative importance of other factors may become greater.

Age therefore provides essential context when assessing recurrent implantation failure.

3. Embryo Development and Biological Competence

Chromosomal status is only one component of embryo biology.

Successful development also depends on:

• Normal cell division
• Gene expression
• Mitochondrial function
• Cellular metabolism
• Appropriate differentiation
• Molecular signaling
• Successful interaction with the endometrium

Many of these characteristics cannot be directly measured during routine embryo assessment.

This helps explain why even apparently excellent blastocysts do not always implant.

4. Uterine Anatomy

The structure of the uterus can influence implantation.

Potential abnormalities include:

• Endometrial polyps
• Submucosal or cavity-distorting fibroids
• Intrauterine adhesions
• Congenital uterine abnormalities
• Certain cases of adenomyosis

Ultrasound provides valuable information about the uterus and endometrium.

Depending on the patient’s reproductive history and previous findings, further investigation may include saline infusion sonography or hysteroscopy.

Identifying and treating clinically relevant abnormalities can be an important part of preparing for another embryo transfer.

5. Endometrial Receptivity

The endometrium undergoes major biological changes during every menstrual cycle.

Under the influence of estrogen and progesterone, endometrial cells prepare for potential embryo implantation.

During this period, numerous processes occur involving:

• Cell adhesion
• Growth factors
• Cytokines
• Immune cells
• Blood-vessel development
• Gene expression
• Molecular communication between embryo and endometrium

This creates the environment in which implantation can occur.

The term endometrial receptivity describes the capacity of the endometrium to interact successfully with an embryo during the appropriate period.

Because this biological process is complex, no single measurement can fully describe endometrial function.

6. Thin Endometrium

Some women repeatedly develop an endometrium that remains thinner than expected despite appropriate preparation.

A persistently thin endometrium can be an important consideration when evaluating implantation difficulties.

Potential contributing factors may include:

• Previous uterine surgery
• Intrauterine adhesions
• Previous endometrial injury
• Hormonal response
• Vascular factors
• Individual biological characteristics

Endometrial thickness is normally assessed using transvaginal ultrasound.

However, thickness alone does not describe every aspect of endometrial quality.

The vascularity, tissue structure and biological activity of the endometrium may also contribute to its ability to interact with an embryo.

This distinction has helped stimulate interest in regenerative approaches designed to support endometrial development and function.

7. Adenomyosis and Endometriosis

Both adenomyosis and endometriosis have been associated with fertility difficulties in selected patients.

Endometriosis involves endometrial-like tissue outside the uterus.

Adenomyosis occurs when endometrial-type tissue is found within the muscular wall of the uterus.

These conditions may influence fertility through several pathways, including inflammation, altered uterine function and changes in the reproductive environment.

If symptoms, ultrasound findings or medical history suggest either condition, further evaluation may be appropriate before another embryo transfer.

8. Chronic Endometrial Inflammation

The endometrial environment can also be influenced by inflammation.

Chronic endometritis is a persistent inflammatory condition of the endometrial lining.

It has attracted increasing interest in women experiencing recurrent implantation failure because chronic inflammation may alter the local environment required for embryo-endometrial communication.

Diagnosis usually involves assessment of endometrial tissue and should be considered according to the patient’s individual history rather than as a universal test after every failed transfer.

When clinically relevant chronic endometritis is identified, appropriate treatment may improve the environment before subsequent embryo transfer.

9. Male Fertility Factors

Repeated implantation failure is frequently discussed as if it were exclusively a female problem.

It is not.

Half of the genetic material of every embryo comes from sperm.

Standard semen analysis evaluates:

• Sperm concentration
• Motility
• Morphology
• Semen volume

However, additional biological aspects of sperm may sometimes be relevant.

One example is sperm DNA fragmentation, which assesses damage to sperm genetic material.

Depending on the couple’s history, male fertility assessment can be an important part of investigating repeated unsuccessful IVF treatment.

Poor embryo development, recurrent pregnancy loss or significant male-factor infertility may provide reasons to investigate further.

10. Embryo Transfer Factors

Successful implantation also requires careful embryo transfer.

Modern ultrasound-guided embryo transfer is generally highly effective, but technically difficult transfers can occasionally influence treatment.

When reviewing previous unsuccessful transfers, the fertility team may consider:

• Was the transfer uncomplicated?
• Was catheter placement straightforward?
• Was ultrasound guidance satisfactory?
• Was there blood or mucus associated with the catheter?
• Were there cervical or anatomical difficulties?

Reviewing the technical aspects of previous transfers can therefore form part of a comprehensive evaluation.

Recurrent Implantation Failure After Euploid Embryo Transfer

The clinical discussion changes when an embryo has undergone Preimplantation Genetic Testing for Aneuploidy (PGT-A) and has been classified as euploid.

A euploid embryo has the expected number of chromosomes according to the cells analyzed.

If repeated euploid embryo transfers do not result in pregnancy, chromosomal aneuploidy becomes a less likely explanation for those particular transfers.

This may increase the importance of evaluating:

• Uterine anatomy
• Endometrial development
• Adenomyosis
• Relevant inflammatory conditions
• Embryo-transfer characteristics
• Other individual reproductive factors

However, even a euploid embryo cannot be expected to implant in every transfer.

PGT-A assesses chromosome number; it does not measure every aspect of embryo metabolism, gene expression or embryo-endometrial communication.

Recurrent Implantation Failure and the Endometrium

For many patients with repeated unsuccessful transfers, the endometrium becomes a central focus of investigation.

This is understandable.

The embryo and endometrium must establish coordinated molecular communication for implantation to occur.

Research into endometrial biology has identified numerous processes that may influence this interaction, including:

• Angiogenesis
• Cell proliferation
• Cellular repair
• Growth-factor signaling
• Cytokine activity
• Immune regulation
• Extracellular matrix remodeling

These mechanisms are also central to the growing field of regenerative reproductive medicine.

Rather than viewing the endometrium simply according to its thickness on ultrasound, regenerative fertility medicine investigates whether the biological environment of the tissue itself may be supported or improved.

What Should Be Investigated After Recurrent Implantation Failure?

Evaluation should begin with a detailed review of what happened during previous IVF cycles.

Important questions include:

What embryos were transferred?
Were they cleavage-stage embryos or blastocysts? What were their grades? Were they genetically tested?

What is the woman’s age?
Age influences the expected probability of embryo competence.

Has pregnancy occurred previously?
Previous natural or IVF pregnancy can provide useful information.

Has the uterine cavity been assessed?
Fibroids, polyps, adhesions or anatomical abnormalities may require attention.

How did the endometrium develop?
Was it persistently thin or otherwise difficult to prepare?

Were the embryo transfers technically straightforward?

Are endometriosis or adenomyosis relevant?

Have male fertility factors been adequately assessed?

The goal is to identify the most plausible factors in the individual patient’s history rather than assume that every recurrent implantation failure case has the same cause.

Endometrial Receptivity Testing

Molecular tests have been developed with the aim of identifying patterns of endometrial gene expression associated with the timing of implantation.

The concept is based on the idea that the optimal implantation window may vary between patients.

These tests can provide additional information in selected circumstances.

Their interpretation should be integrated with the patient’s complete IVF history, embryo characteristics and endometrial preparation rather than used in isolation.

As reproductive medicine evolves, molecular evaluation of the endometrium may become increasingly sophisticated and may ultimately allow more personalized embryo-transfer strategies.

The Immune System and Implantation

The maternal immune system plays an important role in implantation and early pregnancy.

Embryo implantation requires a carefully regulated immune response rather than simple suppression of immunity.

Research has investigated numerous immune pathways involving:

• Natural killer cells
• Cytokines
• T lymphocytes
• Macrophages
• Local inflammatory signaling

The challenge is identifying which immune findings are clinically meaningful in a specific patient.

An individualized approach is therefore preferable to assuming that every unsuccessful implantation reflects an immune problem.

Understanding the immune-endometrial environment remains an important and active area of reproductive research.

PGT-A and Recurrent Implantation Failure

PGT-A can be useful in selected IVF patients because it provides information about embryo chromosome number before transfer.

Its relevance may be particularly important when maternal age increases and the expected frequency of embryo aneuploidy becomes higher.

PGT-A does not improve the intrinsic biological quality of an embryo.

Instead, it assists in embryo selection.

Whether PGT-A is appropriate depends on factors such as:

• Female age
• Number of available blastocysts
• Previous reproductive history
• Previous pregnancy loss
• Previous embryo-transfer outcomes

It should therefore form part of a personalized IVF strategy.

Can Lifestyle Support Implantation?

Lifestyle cannot control every factor involved in implantation, but general reproductive health remains relevant.

Before another embryo transfer, useful considerations can include:

• Avoiding smoking
• Avoiding recreational drugs
• Moderating alcohol consumption
• Maintaining an appropriate body weight
• Following a balanced nutritional pattern
• Regular appropriate physical activity
• Adequate sleep
• Managing chronic medical conditions
• Correcting clinically identified nutritional deficiencies

The objective is to create the best possible physiological environment for fertility treatment and pregnancy.

PRP for Recurrent Implantation Failure

Platelet-Rich Plasma (PRP) has become one of the most important regenerative approaches being investigated and clinically applied to endometrial health.

PRP is prepared from the patient’s own blood.

After processing, the platelet-rich fraction contains concentrated platelets and numerous biologically active molecules, including growth factors and signaling proteins.

These factors participate in processes such as:

• Angiogenesis
• Cell proliferation
• Tissue repair
• Extracellular matrix remodeling
• Cellular signaling
• Inflammatory regulation

When PRP is introduced into the uterine cavity, the objective is to expose the endometrium to this concentrated regenerative environment.

This approach has attracted particular interest in women with:

• Recurrent implantation failure
• Persistently thin endometrium
• Difficult endometrial development
• Previous unsuccessful embryo transfers

Recent evidence is increasingly encouraging.

A 2026 meta-analysis including 10 randomized controlled trials and 1,188 women with recurrent implantation failure found significantly higher clinical pregnancy and live-birth rates following intrauterine autologous PRP compared with controls.

Another 2026 systematic review reported significant improvements in biochemical pregnancy, clinical pregnancy, ongoing pregnancy and live birth following PRP in women with RIF, although variability between protocols remains an important consideration.

These findings contribute to a growing scientific basis for using PRP as part of a targeted regenerative strategy in appropriately selected patients.

Uterine Rejuvenation and Endometrial Regeneration

Uterine rejuvenation aims to support the biological environment of the endometrium rather than focusing solely on endometrial thickness.

The rationale is based on regenerative mechanisms such as:

• Tissue repair
• Angiogenesis
• Growth-factor activity
• Cellular signaling
• Improved tissue response
• Modulation of inflammatory pathways

At Chania Fertility Unit, regenerative fertility strategies can be integrated into an individualized approach for women with implantation difficulties or inadequate endometrial development.

The clinical decision is based on the patient’s IVF history, endometrial characteristics, uterine findings and broader fertility profile.

This is particularly important because recurrent implantation failure is heterogeneous: the same intervention will not necessarily be relevant for every woman.

Experience in Regenerative Fertility Medicine

Regenerative fertility medicine is an important area of expertise associated with the scientific leadership of Dr Matthaios Fraidakis, Scientific Director of Chania Fertility Unit and Crete Fertility Centre.

Crete Fertility Centre has applied regenerative approaches to female fertility since 2016, particularly ovarian PRP and ovarian rejuvenation. The centre reports clinical experience involving thousands of women treated with PRP.

This clinical experience has also generated scientific research.

A peer-reviewed study led by Dr Fraidakis evaluated 469 women receiving intraovarian PRP and reported statistically significant changes in ovarian hormonal parameters following treatment, with the authors reporting an association between PRP administration and improved ovarian tissue and function.

Dr Fraidakis has also presented his experience with PRP and ovarian rejuvenation internationally, including discussion of PRP for improving ovarian response at the 33rd COGI World Congress.

This combination of long-term clinical experience, patient data and continued scientific evaluation forms part of the regenerative fertility approach available through Chania Fertility Unit.

Could Exosomes Support Endometrial Regeneration?

Exosomes represent another rapidly developing area of regenerative medicine.

Exosomes are microscopic extracellular vesicles produced by cells. They transport biological information including:

• Proteins
• Lipids
• Messenger RNA
• MicroRNA
• Other signaling molecules

These vesicles allow cells to influence neighboring or distant cells and are therefore important components of cellular communication.

Within regenerative reproductive medicine, researchers are exploring how exosomal signaling may influence:

• Angiogenesis
• Tissue repair
• Cell proliferation
• Oxidative stress
• Inflammatory balance
• Endometrial regeneration

This is particularly relevant to implantation because communication between cells is fundamental to both endometrial development and embryo-endometrial interaction.

Exosome-based approaches therefore represent an important developing direction within regenerative fertility medicine.

Stem Cell Therapy and the Endometrium

Stem-cell-based approaches offer another regenerative strategy being explored for reproductive tissues.

Mesenchymal stromal/stem cells are of particular interest because they can release numerous biological signals involved in repair and regeneration.

Potential mechanisms relevant to endometrial health include:

• Promotion of angiogenesis
• Cellular repair
• Modulation of inflammation
• Growth-factor release
• Extracellular signaling
• Support of damaged tissue

Importantly, many of the regenerative effects associated with stem cells appear to occur through paracrine signaling—the release of molecules that influence surrounding cells.

This also explains the close biological relationship between stem-cell research and exosome research.

For women with significant endometrial damage or particularly challenging implantation histories, these areas of regenerative medicine are creating additional possibilities for increasingly personalized fertility care.

PRP, Exosomes and Stem Cells: Different Regenerative Strategies

Although these approaches all fall within regenerative medicine, they are biologically different.

PRP uses concentrated platelets and platelet-associated growth factors obtained from the patient’s own blood.

Exosomes use extracellular signaling vesicles that carry molecular information between cells.

Stem-cell approaches use living cells capable of complex regenerative and paracrine signaling.

Rather than viewing them as interchangeable therapies, their potential use should be based on the reproductive problem being addressed and the biological characteristics of the patient.

This is one of the central principles of personalized regenerative fertility medicine.

How Is Treatment Selected After Repeated Implantation Failure?

A regenerative treatment should not be chosen simply because embryo transfers have failed.

The first question should always be:

What appears to be limiting implantation in this particular patient?

For example:

A woman with a persistently thin endometrium presents a different clinical problem from a woman with normal endometrial development but repeated euploid embryo-transfer failure.

A patient with intrauterine adhesions requires different consideration from a patient with adenomyosis.

A woman over 42 transferring untested embryos has a different probability profile from a younger woman repeatedly transferring euploid blastocysts.

Therefore, treatment selection should integrate:

• Age
• Embryo history
• PGT-A status when applicable
• Endometrial thickness and development
• Uterine anatomy
• Previous pregnancies
• Number of failed transfers
• Previous treatment response
• Male fertility factors
• Associated reproductive conditions

This allows both conventional and regenerative strategies to be applied more rationally.

When Should Another Embryo Transfer Be Attempted?

There is no universal waiting period after an unsuccessful embryo transfer.

Timing depends on the reason for the previous failure and whether further assessment or treatment is required.

Factors may include:

• Endometrial recovery or preparation
• Treatment of uterine abnormalities
• Regenerative treatment when selected
• Embryo availability
• Female age
• Medical circumstances
• Emotional readiness

If an intervention is intended to influence the endometrium, the timing of subsequent embryo transfer should form part of the treatment plan.

Can Pregnancy Occur After Recurrent Implantation Failure?

Yes.

Recurrent implantation failure does not mean that pregnancy is no longer possible.

The probability of future pregnancy depends on numerous factors:

• Female age
• Embryo competence
• Number of available embryos
• Euploid embryo availability
• Endometrial health
• Uterine anatomy
• Male fertility
• Underlying reproductive conditions
• Previous pregnancy history
• Treatment modifications

Repeated unsuccessful transfers provide information that can help refine subsequent treatment.

The objective is not simply to perform another identical embryo transfer.

It is to identify which elements of the embryo-transfer pathway can be better understood, optimized or supported before the next attempt.

Frequently Asked Questions About Recurrent Implantation Failure

How many failed embryo transfers are considered recurrent implantation failure?

There is no single number appropriate for every patient. Maternal age, number and quality of embryos transferred, blastocyst development, PGT-A status and individual implantation probability should all be taken into account.

Why do good-quality embryos fail to implant?

Embryo morphology cannot reveal every component of embryo competence. Chromosomal factors, developmental biology, uterine anatomy, endometrial function and embryo-endometrial interaction can all influence implantation.

Can a euploid embryo fail to implant?

Yes. A euploid embryo has the expected chromosome number according to PGT-A, but chromosome number is only one aspect of embryo biology. Implantation also depends on the endometrial environment and complex embryo-maternal communication.

Is recurrent implantation failure the same as IVF failure?

No. IVF failure can occur during ovarian stimulation, egg retrieval, fertilization or embryo development before transfer occurs. Recurrent implantation failure specifically concerns repeated failure to establish pregnancy following embryo transfer.

Can thin endometrium affect embryo implantation?

Persistently thin endometrium may reduce implantation potential in some patients. However, thickness is only one aspect of endometrial biology, and its significance should be considered together with tissue development, uterine anatomy and reproductive history.

Can PRP help recurrent implantation failure?

Growing clinical research supports the potential role of intrauterine PRP for selected women with recurrent implantation failure. A 2026 meta-analysis of 10 randomized trials involving 1,188 women found significantly improved clinical pregnancy and live-birth rates following PRP treatment. Individual treatment decisions should take into account endometrial characteristics, previous embryo transfers and the patient’s overall fertility profile.

How can PRP support the endometrium?

PRP contains concentrated platelets and associated growth factors that participate in angiogenesis, cellular signaling, tissue repair and regeneration. These mechanisms provide the biological basis for its application in endometrial preparation and uterine rejuvenation.

What is uterine rejuvenation?

Uterine rejuvenation refers to regenerative strategies aimed at supporting endometrial tissue and its biological environment. PRP is one of the best-studied approaches, while exosomes and stem-cell-related strategies represent additional areas of regenerative fertility medicine.

When should I consider further evaluation after failed embryo transfers?

Evaluation becomes particularly important when implantation failure occurs repeatedly, especially after transfer of high-quality or euploid embryos. The number of previous transfers, age, embryo characteristics, uterine anatomy and endometrial development should all influence the decision.

Recurrent Implantation Failure: Building a More Personalized Strategy

Recurrent implantation failure is not a single disease with one universal explanation.

Successful implantation depends on the embryo, endometrium, uterus and the complex biological communication between them.

This is why repeated unsuccessful embryo transfers should lead to a structured review of the complete treatment pathway:

Embryo development → embryo competence → maternal age → uterine anatomy → endometrial development → embryo transfer → male fertility → associated reproductive conditions.

For some women, embryo competence may remain the dominant factor.

For others, uterine or endometrial conditions may provide an important therapeutic target.

And for selected patients, regenerative fertility approaches can provide additional strategies for supporting ovarian or endometrial function.

At Chania Fertility Unit, this evaluation is supported by the clinical and scientific experience of Dr Matthaios Fraidakis, whose work in regenerative fertility medicine extends back to 2016 and includes extensive experience with PRP-based reproductive treatments and published clinical research.

The objective following recurrent implantation failure is not simply to repeat embryo transfer.

It is to understand as much as possible about why previous transfers were unsuccessful, identify factors that can be addressed, and combine conventional reproductive medicine with appropriate regenerative strategies to create a more personalized path toward pregnancy.